OpenAI is capping off a busy week of announcements with the release of GPT-5.5, its latest model upgrade for ChatGPT and Codex. The company calls its new model “a new class of i ...
Our Goal In the fast-evolving landscape of AI, we saw an opportunity to revolutionize local election coverage in our newsroom by reducing manual, repetitive tasks so our journalists could focus on ...
Choosing between SAML, OIDC, and OAuth 2.0? Explore 12 critical differences to help your B2B engineering team select the right authentication protocol today.
In a battle of past Charleston champions, Madison Keys rallied in three sets to knock off Belinda Bencic and advanced to her first semifinal of 2026. CHARLESTON, S.C. -- That's four Charleston ...
OPPO has started rolling out a new set of updates under ColorOS 16, bringing incremental but practical changes focused on security, usability, and everyday convenience. The rollout began on March 16 ...
Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...
Editing AI-generated images can be made more precise by incorporating JSON with platforms like Gemini. According to Teacher’s Tech, this approach enables users to make specific changes, such as ...
Microsoft’s New Windows 11 Update Fixes File Explorer’s Annoying ‘White Flash’ Your email has been sent Microsoft has rolled out Windows 11 Insider Preview ...
If there’s one universal experience with AI-powered code development tools, it’s how they feel like magic until they don’t. One moment, you’re watching an AI agent slurp up your codebase and deliver a ...
Covering the video games industry since 2017, with experience in news, articles, lists, and reviews (and I blame The Legend of Zelda: Majora's Mask for that). If you are a fan of RPGs and want a third ...
Roche Holding said a drug candidate for multiple sclerosis met the primary goal in a late-stage clinical trial for the most common form of the disease. The Swiss pharmaceutical company said Monday ...
Roche Holding said a drug candidate for multiple sclerosis met the primary goal in a late-stage clinical trial for the most common form of the disease. The Swiss pharmaceutical company said Monday ...